Neuromind Biopharma is a biotech company drawing on the extensive experience of its directors, advisory board members and networks of expertise in research and development in the bio–pharmaceutics space. Our entry into the psychedelic arena is backed by its long history of developing therapeutics of natural origin and taking the lead from nature. We wish to further the science of harnessing the extensive source of tryptaminergic compounds from nature’s pantry.

Advancements in the biosciences increasingly demonstrate the need for diversity and versatility in bio-drug development that draws on our understanding of co-evolved metabolic pathways. There is no better example than the meta-tryptophan biome, co-evolved and differentiated across all species and kingdoms as a source of biologics for new therapeutics that impact on multiple metabolic regulatory cycles. Our scientific innovation is truly led and informed by our further understanding of the intricacies of metabolomics between all lifeforms.